Monday, August 2, 2021

FDA May Grant Full Approval For Pfizer Jab As Early As September

The Food and Drug Administration may grant full approval for Pfizer's Covid-19 vaccination as early as September or October, according to the Wall Street Journal, citing FDA advisers and former officials familiar with the process.

The rush for full approval - as opposed to the current emergency use authorization - comes as many schools, hospitals and employers have used full approval as a benchmark for moving forward with mandatory vaccinations.

Three vaccines-from Pfizer Inc. and partner BioNTech SE, Moderna Inc., and Johnson & Johnson -are authorized for emergency use in the U.S. Pfizer and Moderna have filed initial paperwork for full approval.

The FDA is taking an "All-hands-on-deck" approach to review Pfizer's applicaiton for full approval "As rapidly as possible in keeping with the high-quality complete assessment that the public expects from the FDA.".

As the Journal notes, full approval will ease restrictions on distribution and advertising, and will allow more states, schools and employers to force people to take the jab, according to attorneys and current/former FDA officials.

According to a June Kaiser Family Foundation survey, over 30% of unvaccinated Americans would be more likely to get it if the FDA grants full approval.

"If you're a company operating in all 50 states and even internationally, it's hard for them to move on the vaccine mandate and having a full FDA approval and authorization would make that easier."

https://www.nationandstate.com/2021/08/01/fda-may-grant-full-approval-for-pfizer-jab-as-early-as-september/ 

No comments:

Post a Comment